7776 — CellSeed Cashflow Statement
0.000.00%
- ¥15bn
- ¥14bn
- ¥193m
Annual cashflow statement for CellSeed, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -780 | -911 | -759 | -846 | -858 |
| Depreciation | |||||
| Non-Cash Items | 67.6 | 51.6 | 17.5 | 149 | 15 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.97 | 39.5 | 15.3 | -90.8 | -23.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -701 | -817 | -718 | -779 | -866 |
| Capital Expenditures | -10.3 | -91 | -15.6 | -21.6 | -18.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2.33 | -19.4 | 77.3 | 77.9 | — |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -12.6 | -110 | 61.7 | 56.3 | -18.4 |
| Financing Cash Flow Items | 4.25 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,103 | 397 | 882 | 1,814 | 855 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 396 | -530 | 226 | 1,091 | -29 |